The cymA gene, which encodes a tetraheme cytochrome c, was cloned from Shewanella putrefaciens MR-1. This gene complemented a mutant which had a TnphoA insertion in cymA and which was deficient in the respiratory reduction of iron(III), nitrate, fumarate, and manganese(IV). The 561-bp nucleotide sequence of cymA encodes a protein of 187 amino acids with a predicted molecular mass of 20.8 kDa. No N-terminal signal sequence was readily apparent; consistent with this, a cytochrome with a size of 21 kDa was detected in the wild type but was absent in the insertional mutant. The cymA gene is transcribed into an mRNA; the major transcript was approximately 790 bases, suggesting that it is not part of a multicistronic operon. This RNA transcript was not detected in the cymA mutant. The CymA protein was found in the cytoplasmic membrane and soluble fraction of MR-1, and it shares partial amino acid sequence homology with multiheme c-type cytochromes from other bacteria. These cytochromes are ostensibly involved in the transfer of electrons from the cytoplasmic membrane to acceptors in the periplasm. The localization of the fumarate and iron(III) reductases to the periplasm and outer membrane of MR-1, respectively, suggests the possibility of a similar electron transfer role for CymA.
Shewanella putrefaciens MR-1 (35-37, 40, 41, 43 ) is a gramnegative facultative anaerobe that can couple its anaerobic growth and link respiratory proton translocation to the reduction of a variety of compounds including fumarate, nitrate, trimethylamine-N-oxide (TMAO), manganese(IV) oxides, iron(III) oxides, and others (28, 40, 42, 43) . Previous studies implicate respiratory electron transport components in the reduction of manganese (Mn) and iron (Fe) oxides by MR-1. Antimycin A and HQNO (2-heptyl-hydroxyquinolone-N-oxide) inhibit cellular Mn(IV) and Fe(III) reduction (39, 40) , proton translocation in response to Mn(IV) and Fe(III) (43) , and the Fe(III) reductase activity of its outer membrane (37) . Formate, an effective electron donor in anaerobic respiration but not in substrate-level phosphorylation (24, 55) , can serve as an electron donor for the reduction of Fe(III) and Mn(IV) by MR-1 (28, 37, 39) .
MR-1 requires menaquinone and/or methylmenaquinone for the reduction of Fe(III) and nitrate and for growth on fumarate but not for growth on TMAO (38) . Similarly, menaquinone and/or methylmenaquinone is preferred over ubiquinone for Mn(IV) reduction. These menaquinone data provide further support that the metal-reducing systems in MR-1 are linked to anaerobic respiration.
This report describes the isolation of a gene, cymA, that restores the ability of a previously isolated mutant CMTn-1 (38) to reduce Fe(III) and nitrate and to grow on fumarate. It also restores, to wild-type levels, the ability to reduce Mn(IV). The DNA sequence and deduced amino acid sequence of cymA indicate that it codes for a tetraheme cytochrome c with a molecular mass of approximately 21 kDa. Heme-stained gels confirm the presence of this cytochrome in MR-1, as well as its absence in the mutant CMTn-1.
MATERIALS AND METHODS

Materials. Tris, N-(2-hydroxyethyl)-piperazine-NЈ-(2-ethanesulfonic acid) (HEPES)
, sodium dodecyl sulfate (SDS), dithiothreitol, boric acid, citric acid trisodium, fumaric acid disodium, disodium EDTA, and 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside were purchased from Research Organics (Cleveland, Ohio). Acrylamide, formamide, and glycine were from EM Science (Gibbstown, N.J.). Tryptone, yeast extract, and bacteriological agar were from Oxoid (Unipath, Ltd., Hampshire, England). Agarose was from FMC BioProducts (Rockland, Maine). NaCl, 37% formaldehyde, urea, and 3-(N-morpholino)propanesulfonic acid (MOPS) were from Fisher Scientific. ␤-Agarase I, CircumVent Phototope Thermal Cycle DNA Sequencing Kit, Exo-Size Deletion Kit, Phototope Detection Kit, Vent R DNA polymerase, biotinylated HindIII DNA markers, biotinylated T7 and SP6 universal primers, and biotinylated M13/pUC forward (Ϫ47) and reverse (Ϫ48) sequencing primers were from New England BioLabs (Beverly, Mass.). Proteinase K, calf intestinal alkaline phosphatase, and some restriction enzymes were from Promega (Madison, Wis.). DNA polymerase (Klenow fragment), RNAguard RNase inhibitor, RNase-free FPLCpure DNase I, and some restriction enzymes were from Pharmacia Biotech (Piscataway, N.J.). T4 DNA ligase was from Promega or Life Technologies (Gaithersburg, Md.). Herring sperm DNA and the Packaging Kit were from Boehringer Mannheim (Indianapolis, Ind.). Deoxynucleotides were from Stratagene (La Jolla, Calif.), and Immobilon S nylon membranes were from Millipore (Bedford, Mass.). Rifampin was from U.S. Biochemical Corp. (Cleveland, Ohio), and ethidium bromide, phenol-chloroform, and buffered phenol were from Amresco (Solon, Ohio). RNA markers were from Novagen (Madison, Wis.). X-Omat AR and BioMax MR X-ray film were from Eastman Kodak (Rochester, N.Y.). All other reagents and chemicals were from Sigma (St. Louis, Mo.) or Aldrich Chemical (Milwaukee, Wis.). Custom oligonucleotide primers containing 5Ј-biotin were synthesized by Genemed Biotechnologies (South San Francisco, Calif.) or by Operon Technologies (Alameda, Calif.).
Bacterial strains, plasmids, media, and growth conditions. A list of the bacteria and plasmids used in this study is presented in Table 1 . For molecular biology purposes, S. putrefaciens and Escherichia coli were grown aerobically on Luria-Bertani (LB) medium (51) supplemented, when required, with the following antibiotics at the concentrations indicated: rifampin (Rf), 50 g ml Ϫ1 ; tetracycline, 20 g ml
Ϫ1
; ampicillin, 50 g ml Ϫ1 ; and kanamycin, 50 g ml Ϫ1 . S. putrefaciens and E. coli were grown at room temperature (23 to 25ЊC) and 37ЊC, respectively. For other purposes, S. putrefaciens was grown at room temperature either aerobically or anaerobically as previously described (36) in defined medium (43) supplemented with 15 mM lactate and vitamin-free Casamino Acids (0.1 g liter Ϫ1 ). For anaerobic growth or for testing electron acceptor use, the medium was supplemented with one of the following electron acceptors as indicated: 20 mM TMAO, 20 mM fumarate, 10 mM ferric citrate, 2 mM nitrate, or 5 mM MnO 2 . For growth on TMAO, the medium was also supplemented with 30 mM HEPES to buffer against alkalinization by the product trimethylamine. Antibiotics were included when needed at the concentrations listed above.
DNA manipulations.
Restriction digestion, mapping, ligation, cloning, subcloning, DNA electrophoresis, Southern transfer, and the isolation of genomic DNA from S. putrefaciens were done according to standard techniques (51) . Isolation of plasmid and cosmid DNA was accomplished by using standard techniques (51, 65) , or commercial kits (QIAprep Spin Plasmid kit [Qiagen, Chatsworth, Calif.] or Circleprep Spin Midi kit [Bio101, Vista, Calif.]). The sizes of DNA fragments, RNA, and proteins were estimated based on their relative electrophoretic mobilities to known standards by using a computer program kindly provided by G. Raghava (49) . DNA probes were labelled with biotin by using the Random Primed Images Biotin Labelling Kit (U.S. Biochemical Corp.), and Southern blots were developed by using the Phototope Detection system (New England BioLabs).
Aerobically grown mid-logarithmic-phase E. coli cells were prepared for electroporation as suggested by Bio-Rad; the cells were stored in 10% glycerol at Ϫ80ЊC until needed. Plasmids and cosmids were introduced into E. coli by electroporation by using 0.1-cm cuvettes (BTX, Inc., San Diego, Calif.) and a Bio-Rad Gene Pulser with a pulse controller (resistance, 200 ⍀; capacitance, 25 F; voltage, 1.5 kV). After electroporation, the cells were immediately suspended in 1.0 ml of SOC broth (51) and incubated at 37ЊC for 60 min prior to being plated on LB agar with the appropriate antibiotics.
DNA sequencing and sequence analysis. The 5.5-and 1.7-kb HindIII fragments of pTN5 were purified from agarose gels by using ␤-agarase I and subcloned into pUC19 and pGEM-7Zf(ϩ). These subclones and their nested deletions (generated by using the Exo-Size Deletion Kit), as well as pTN5 and pCMTN1-VK, were used as templates for thermal cycle DNA sequencing; the reactions were accomplished by using an MJ Research (Watertown, Mass.) programmable thermal controller. Various biotinylated sequencing primers were used as determined by the template, including custom primers, M13/pUC, T7, and SP6 primers. The sequencing reaction mixtures were run on either 6 or 8% polyacrylamide gels with 8.3 M urea in Tris-borate-EDTA buffer at a constant power of 60 to 70 W. The gels were blotted onto nylon membranes, which were then developed by using the Phototope Detection System and BioMax MR film as recommended by the manufacturer. The DNA sequence was verified by sequencing both strands.
Computer-assisted sequence analysis was done with MacVector software (IBI, New Haven, Conn.). Comparison to sequences on deposit in GenBank, EMBL, SWISS-PROT, and PIR-Protein databases was done by using the Wisconsin Sequence Analysis Package of the Genetics Computer Group software and the BLAST program (2) .
Northern blotting. Total RNA was purified from anaerobically grown MR-1 by an adaptation of the hot phenol method described by Wilson et al. (62) . The culture (100 ml) was sealed in centrifuge bottles prior to removal from the anaerobic chamber. The cells were pelleted at 3,840 ϫ g for 20 min at 4ЊC in a Beckman JA-14 rotor. The pellets were resuspended in 0.35 ml of 0.3 M sucrose-10 mM sodium acetate (pH 4.5) on ice. They were transferred to 2-ml microfuge tubes containing 0.35 ml of 2% SDS-10 mM sodium acetate (pH 4.5) and incubated for 4 min at 65ЊC. After 0.70 ml of buffered phenol (pH 4.5) was added and thoroughly mixed, the tubes were incubated for an additional 3 min at 65ЊC. They were centrifuged for 5 min at 11,750 ϫ g in an Eppendorf 5415C microcentrifuge. The upper aqueous layer was extracted twice with phenol (pH 4.5)-chloroform (5/1 [vol/vol]) and once with chloroform. RNA was precipitated for 2 h at Ϫ20ЊC after the addition of 0.1 volume of 3 M sodium acetate (pH 5.2) and 2.5 volumes of 100% ethanol. The pellet was washed in 70% ethanol and dried under vacuum. The RNA pellets were suspended in 40 l of 10 mM Tris-HCl (pH 7.5)-7 mM MgCl 2 -1 mM dithiothreitol containing 152 U of RNAguard and 40 U of RNase-free DNase. After incubation for 40 min at 37ЊC, the RNA was purified by extraction with phenol-chloroform and chloroform and ethanol precipitation. The final pellets were suspended in 15 l of RNase-free water and stored at Ϫ80ЊC until use. All standard precautions to prevent RNase contamination were followed (51) .
Northern blot analysis was done by a modified version of the method described by Sambrook et al. (51) . RNA (11 l) was mixed with 11 l of loading buffer (22 mM MOPS, 1.1 mM EDTA, 50% formamide, 6.5% glycerol, 6.5% formaldehyde) and 0.167 l of ethidium bromide (10 mg ml Ϫ1 ) and electrophoresed for 2 h at 50 V in a 1.2% agarose minigel (containing 20 mM MOPS, 1 mM EDTA, and 2% formaldehyde). The gel was then sequentially soaked (20 to 30 min each) in 50 mM NaOH-0.1 M NaCl, 0.1 M Tris-HCl (pH 7.5), and 10ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate). The RNA was transferred to a nylon membrane by capillary blotting overnight by using 10ϫ SSC; after the membrane was air dried, the RNA was fixed to the membrane by UV crosslinking (33 mJ cm Ϫ2 ). The membrane was prehybridized in H buffer (6ϫ SSC, 5ϫ Denhardt's solution, 0.5% SDS, 0.1 mg of sheared herring sperm DNA per ml) for 1 h at 60ЊC and hybridized in H buffer with 20 ng of biotin-labelled probe per ml overnight at 60ЊC. Two posthybridization washes for 5 min (each) at 23ЊC in 2ϫ SSC-0.1% SDS and two washes for 15 min (each) at 55ЊC in 0.1ϫ SSC-0.1% SDS were done prior to development of the blots with the Phototope Detection System. Miscellaneous procedures. Growth was assessed by measuring total cellular protein as previously described (39) . Nitrate (10) and nitrite (59) were determined colorimetrically in cell-free filtrates. Fe(II) was determined by a ferrozine extraction procedure (26, 41) . Mn(II) was determined in filtrates by a formaldoxime method (3, 8) , and MnO 2 was prepared as described previously (40) .
Cytoplasmic membrane (CM), intermediate membrane (IM), outer membrane (OM), and soluble fractions (periplasm plus cytoplasm) were purified from cells by an EDTA-lysozyme-Brij protocol as previously described (36) . The IM is a hybrid of CM and OM (36) . The separation and purity of these subcellular fractions were assessed by determination of the spectral cytochrome content (36) , NADH oxidase activity (45) , membrane buoyant density (36) , fumarate reductase (35) , and SDS-polyacrylamide gel electrophoresis (PAGE) gels (25, 32) stained for protein with Coomassie blue or for heme as previously described (36) . Protein was determined by the Lowry method (29) modified as described by Collins and Hughes (14) , with bovine serum albumin as the standard.
Nucleotide sequence accession number. The DNA sequence reported herein (see Fig. 4 ) has been submitted to GenBank and has been assigned accession no. U75974. 
RESULTS
The mutant CMTn-1, which was previously generated by transposon (TnphoA) mutagenesis of MR-1A (38) , cannot use nitrate, Fe(III), or fumarate as an electron acceptor, and it exhibits a reduced rate of Mn(IV) reduction but retains the ability to use TMAO (38) . While it resembles MR-1 with respect to the level, expression, and subcellular distribution of formate dehydrogenase (38) , it has only 2 to 4% of the wildtype level of formate-dependent Fe(III) reductase (38) . In addition, while it cannot grow by using fumarate as an electron acceptor, it retains an active benzyl viologen-linked fumarate reductase activity (38) .
Determination of the site of TnphoA insertion in CMTn-1. Southern blot analysis of CMTn-1 genomic DNA with TnphoA as a probe indicated that TnphoA is inserted at a single location in the genome of CMTn-1 (data not shown). To specifically identify this site of TnphoA insertion, we prepared a genomic library by ligating partially Sav3A1-digested CMTn-1 genomic DNA into the alkaline phosphatase-treated BamHI site of pUC19; kanamycin was used to select for clones that contained TnphoA DNA. Restriction fragment analysis demonstrated that many of these recombinant plasmids contained flanking genomic DNA from CMTn-1, i.e., at least part of the gene that was interrupted by TnphoA. With one of these plasmids (pCJ18) as a template, we obtained DNA sequence (using a custom primer complementary to phoA, which is very near one end of TnphoA [5, 11] ) that extended off the end of TnphoA into the flanking CMTn-1 genomic DNA (Fig. 1) . A search of GenBank failed to identify significant homology between this flanking DNA and known nucleotide sequences.
Isolation of MR-1 DNA that complements CMTn-1. To isolate wild-type DNA that complements CMTn-1, a genomic library of MR-1 was constructed by ligating partially HindIIIdigested MR-1 genomic DNA (20 to 30 kb in size) into the HindIII site of the cosmid pVK100, which is known to replicate in S. putrefaciens (18) . The recombinants were packaged in phage, and the recombinant phage were used to transform E. coli S17-1. Several thousand E. coli transformants were pooled and mated with CMTn-1. Each mating mixture was serially diluted and inoculated into defined medium with lactate, Fe(III), and antibiotics. The desired transconjugants were isolated by their ability to grow anaerobically with Fe(III) as the electron acceptor and were subsequently confirmed to have regained the use of all anaerobic electron acceptors. Complementing cosmids were purified from several transconjugants, and while some had identical restriction patterns (pTN1, -5, and -7), one of them (pTN11) had some differences. To ascertain what was common to these complementing cosmids, we pursued analysis of pTN5 and pTN11; they were electroporated into E. coli S17-1, and from there they were mated back into CMTn-1 to confirm that they retained the ability to revert CMTn-1 to the wild-type phenotype.
Restriction analysis indicated that three HindIII fragments (5.5, 3.0, and 1.7 kb) were common to pTN5 and pTN11; a partial restriction map of this common region is shown in Fig.  2A . A probe derived from the Tn-flanking DNA (Fig. 1) hybridized to the 5.5-kb HindIII fragment in these cosmids, as well as to a 5.5-kb HindIII fragment in MR-1 genomic DNA (data not shown); these complementing cosmids therefore contain DNA that corresponds to the region of the TnphoA insertion in CMTn-1. This probe did not hybridize to the cloning vector pVK100, pUC19, or pUI800 (data not shown).
pTN5 was chosen for further studies to elucidate the identity of the DNA that complements CMTn-1. By using a combination of custom primers and nested deletions, 2,746 bp of pTN5 DNA that spans the region corresponding to the TnphoA insertion site in CMTn-1 was sequenced. The sequence data revealed that this region contains several putative open reading frames (ORFs) (Fig. 2B) . A comparison to the sequence in Fig. 1 indicated that, in CMTn-1, the TnphoA was inserted within a 561-bp ORF that extends from the 5.5-kb HindIII fragment into the adjacent 1.7-kb HindIII fragment (Fig. 2) . More specifically, the TnphoA insertion was within the 5.5-kb fragment, consistent with the Southern blot data (described above).
Identification of the ORF that complements CMTn-1. Various regions of the pTN5 insert were subcloned to identify the smallest region able to complement CMTn-1. By itself, none of the HindIII fragments (5.5, 3.0, and 1.7 kb) cloned into pVK100 was able to complement CMTn-1 (Fig. 3) . Except for the ORF from bases 866 to 1426, which overlaps the 5.5-and 1.7-kb fragments, all other ORFs with their associated 5Ј and 3Ј ends were contained within one of these three HindIII fragments. This eliminated all possible ORFs except the one spanning bases 866 to 1426; this ORF is also the site of TnphoA insertion in CMTn-1.
To subclone this 561-bp ORF with its associated 5Ј and 3Ј regions, a fragment corresponding to the region between nucleotides 604 and 1592 was synthesized with pTN5 as a template, high-fidelity Vent R DNA polymerase, and the following custom oligonucleotide primers 5Ј-CTACTCGAGTGCCTTA GCTACTTAAGGTG (forward) and 5Ј-CAACTCGAGTTAT CAGTGATGCTTGTACC (reverse) (the XhoI sites added to the 5Ј end of each primer are underlined); the buffer and thermal cycling conditions used were those recommended by New England BioLabs. The resulting 1,006-bp product, which includes the entire 561-bp ORF and 262 and 166 bp of associated 5Ј and 3Ј DNA, respectively, was digested with XhoI and cloned into the XhoI site of pVK100, generating pCMTN1-VK. The DNA sequence of this XhoI insert was obtained to verify that the correct sequence had been amplified and that it did not contain any errors. This insert in pCMTn1-VK did revert CMTn-1 to the wild-type phenotype, including reduction of Fe(III), Mn(IV), and nitrate (Table 2 ). Growth on fumarate was also restored by pCMTN1-VK but only to a level of about 30% of the wild-type MR-1A level.
In these studies, tetracycline was included to select for maintenance of pCMTN1-VK. The vector without an insert (pVK100) was placed in strains MR-1A and CMTn-1 (Table  2) , which allowed for tetracycline use with these strains as well. Anaerobic growth for all three strains was significantly slower in the presence of tetracycline than in its absence, so direct comparisons cannot be made between the rates shown in Table  2 and those in previous studies in which vectors encoding tetracycline resistance were not used (37) (38) (39) (40) (41) . The use of tetracycline with all strains listed in Table 2 , however, does allow for an accurate assessment of relative growth. That tetracycline significantly slowed their growth is not surprising as tetracycline resistance markers code for a protein which mediates active tetracycline efflux (21), a process which requires energy. Since anaerobic respiration is generally much less efficient than aerobic respiration, it seems likely that these anaerobic cells must expend a significant percentage of their energy for tetracycline efflux. Nonetheless, even though tetracycline slows their anaerobic growth, the timing of the onset of growth of CMTn-1(pCMTN1-VK) was very similar to that of MR-1A(pVK100).
The nucleotide sequence of the insert in pCMTN1-VK which complements CMTn-1 is shown in Fig. 4 . The 561-bp ORF starts at ATG (position 866) and ends at TAA (position 1427). It encodes a putative polypeptide of 187 residues, with a calculated molecular mass of 20.8 kDa and an estimated isoelectric point of 9.2. It contains a putative ribosome-binding site (50) 10 bases upstream of the start codon and a putative prokaryotic factor-independent RNA polymerase terminator 30 bases downstream of the stop codon. This ORF contains four putative binding domains for heme c (CXXCH) (20) , which correspond to amino acids 46 to 50, 75 to 79, 136 to 140, and 173 to 177. Hereafter we refer to the ORF encoding this cytochrome c as cymA. The site of TnphoA insertion in CMTn-1 was 43 amino acid residues (23%) from the N terminus of CymA and prior to the first heme c-binding site.
A Kyte-Doolittle hydrophilicity plot of the predicted amino acid sequence of CymA (Fig. 5) indicates a strongly hydrophobic region of about 20 residues near the N terminus followed by a region of mixed residues which extends just past the midpoint of the protein. The remainder of the protein extending to its C terminus is strongly hydrophilic. The hydrophobic N terminus of CymA may serve to anchor it in the cytoplasmic membrane. Since the size of the CymA protein closely matches that predicted from the nucleic acid sequence, it seems unlikely that this N terminus is removed as a signal sequence.
To assess whether the cymA ORF is transcribed, Northern blot analysis of total RNA from MR-1 cells grown anaerobically with fumarate or TMAO as the electron acceptor was conducted. With the 1-kb insert in pCMTN1-VK as a probe, the major RNA detected in MR-1 grown anaerobically with TMAO or fumarate was approximately 790 bases (Fig. 6 ). This size is consistent with an expected transcript from the 561-bp cymA ORF and would include a total of approximately 230 bases of untranslated 5Ј and 3Ј RNA. This RNA was absent in the mutant CMTn-1 (Fig. 6) . A less prominent band with a size of approximately 1,000 bases was seen with MR-1 but not with the mutant CMTn-1. It is possible that these two RNA transcripts result from two different transcriptional start sites; alternatively, the smaller one could represent a processed fragment of the larger transcript. Nonetheless, it is clear that cymA is transcribed into RNA in the wild type and that this RNA is absent in the mutant CMTn-1.
Evidence that the cymA gene encodes a c-type cytochrome. To assess if the cymA mRNA is translated into a cytochrome c with the expected size, we examined subcellular fractions of MR-1 and CMTn-1. These subcellular fractions were prepared as described in previous studies (35) (36) (37) ; analysis of these fractions for NADH oxidase activity, considered a marker for the CM (45, 53) , demonstrated that its specific activity was threefold greater in the CM than in the OM (Table 3 ). The distribution of cytochromes was similar to that previously reported (36) , although the total cytochrome levels in the OM were approximately one-third of those reported for fumarate-grown cells (36) . Specific fumarate reductase activities were 20-to 30-fold higher in the soluble fraction than in the other fractions (Table 3) , with Ͼ98% of the total fumarate reductase activity in the soluble fraction. This is consistent with previous findings (35, 38) and the periplasmic location of this enzyme (31, 35, 48) . Analysis for membrane buoyant density and SDS-PAGE patterns (Fig. 7) confirmed a prominent separation of the various subcellular fractions. An absolute separation of these subcellular compartments has not been achieved in any bacterium, but these S. putrefaciens fractions are separated to an extent similar to that reported for other bacteria (15, 16, 19, 33, 34, 44, 45, 52, 53) and are comparable to the analogous fractions from previous experiments (35) (36) (37) .
Heme staining for c-type cytochromes is feasible since heme c is covalently bound to protein and is therefore not dissociated from the protein by the strongly denaturing conditions of SDS-PAGE. Because the mutant CMTn-1 is limited in its anaerobic respiratory capacity, cells were grown anaerobically with TMAO as the electron acceptor for these studies. Hemestained SDS-PAGE did show one difference between the wild type and CMTn-1. A heme-positive protein with a molecular mass of about 21.4 kDa was seen in the cytoplasmic membrane and soluble fraction of MR-1 but was absent from the mutant CMTn-1 (Fig. 7B) . A heme-positive band migrating at the same position was also seen in MR-1 cells grown anaerobically with fumarate ( Fig. 8 ) and in cells grown under aerobic conditions (data not shown). Northern blotting confirmed the expression of cymA in fumarate-and TMAO-grown MR-1 cells and the lack of expression of cymA in CMTn-1 (Fig. 6) . One would expect any truncated CymA product in CMTn-1 to be heme negative, since the TnphoA insertion in CMTn-1 is prior to the first heme-binding site of CymA (Fig. 4) . The protein size of 21.4 kDa is essentially the same as the molecular mass of 20.8 kDa predicted from the nucleotide sequence, which suggests that the CymA protein is not processed from a larger precursor. Consistent with this, a typical bacterial secretory signal sequence (61) or signal peptidase cleavage site (60) could not be identified in CymA. However, since there is only one reported example of a secretory signal sequence for a periplasmic protein in S. putrefaciens (31, 48) , further studies will be necessary to definitively address this issue with CymA.
CymA is found in both the soluble and cytoplasmic membrane fractions (Fig. 7B ) of TMAO-grown cells, so it is unclear whether it is a periplasmic or CM-bound protein. In repeat The lower lines show the various fragments derived from this clone that were tested for their ability to complement CMTn-1. All fragments were cloned into the HindIII site of pVK100, except for pCMTN1-VK in which the fragment was cloned into the XhoI site of pVK100 by using XhoI sites that were engineered into the primers used to generate this fragment. The 561-bp ORF contained in the small fragment that complements CMTn-1 is designated cymA. Complementation of CMTn-1 (indicated as "YES") was evident as rapid and complete reduction of 10 mM Fe(III) citrate within 4 days, with rates comparable to those of MR-1A. Inability to complement CMTn-1 ("NO") indicates a lack of significant Fe(III) reduction even after a period of 1 month. Restriction sites: H, HindIII; X, XhoI; S, SacI. subcellular fractionations of MR-1, CymA was much more prominent in the CM than in the soluble fraction (Fig. 8) , suggesting that it is a CM protein. It is possible that the Brij 58 detergent used during the subcellular fractionation caused the release of some CymA into the soluble fraction. Certain other c-type cytochromes, including the nitrite reductase of Paracoccus denitrificans, are loosely associated with the periplasmic face of the CM and are easily removed (even by changes in ionic strength) and may therefore also partially appear in the periplasm (1, 9) .
DISCUSSION
From the perspective of respiratory versatility, S. putrefaciens MR-1 is arguably the most versatile bacterium studied to date. MR-1 can obtain energy from the reduction of a variety of insoluble and soluble metal oxides, including Mn(III/IV), Fe(III), and uranium(VI) (27, 28, 39, 40, 42, 43) , in addition to the electron acceptors used by certain other bacteria (e.g., oxygen, fumarate, nitrate, nitrite, TMAO, DMSO, sulfite, thiosulfate, tetrathionate [28, 40, 42, 43] ). This versatility predicts a potentially complex electron transport system with some potentially unique components. MR-1 contains numerous respiratory electron transport components, including three quinones (ubiquinone, menaquinone, and methylmenaquinone) (38) , and several c-and b-type cytochromes localized in various subcellular regions (36) . Previous reports have demonstrated key differences other than its ability to utilize insoluble substrates (e.g., Mn and Fe oxides) as electron acceptors between the electron transport chains of MR-1 and those of other bacteria: (i) MR-1 localizes a majority of its membrane-bound cytochromes to its OM when grown under anaerobic conditions (36), (ii) the fumarate reductase of MR-1 is a periplasmic enzyme (31, 35, 48) in contrast to the membrane-bound forms in other bacteria, and (iii) in direct contrast to E. coli, menaquinone is required for nitrate reduction in MR-1 but is not required for TMAO reduction (38) .
Compared to the wealth of knowledge on anaerobic respiratory systems in other bacteria (e.g., E. coli, P. denitrificans, and Wolinella succinogenes), relatively little is currently known about S. putrefaciens. The data reported here demonstrate a role for a 21-kDa cytochrome c (CymA) in some, but not all, forms of anaerobic electron transport-linked respiration in MR-1. The absence of CymA results in an inability to grow on fumarate and to reduce nitrate or Fe(III), as well as a marked deficiency in Mn(IV) reduction. CymA is not, however, required for TMAO use. These results imply that CymA is a necessary component of the electron transport chain that is common to the reduction of fumarate, nitrate, and Fe(III); this pathway also seems to be the most efficient for the reduction of Mn(IV). It seems likely that CymA is somewhere in the middle of these electron transport chains and that the chains diverge to separate components somewhere after CymA. There are several observations which support this. First, formate can serve as the electron donor for these systems, and CMTn-1 resembles the wild type with respect to content and distribution of formate dehydrogenase (38) . Second, the terminal reductases that are ultimately linked to CymA are differentially localized in MR-1; e.g., the fumarate reductase is periplasmic (31, 35, 48) , while the Fe(III) reductase is in the OM (37). Biochemical and mutant phenotype evidence further suggests the presence of unique terminal reductases for Fe(III), Mn(IV), and nitrate (4, 17, 37, 42, 43) . Hence, while CymA is required for the reduction of several anaerobic electron acceptors, it does not likely serve as the terminal reductase for these oxidants. Furthermore, these CymA-dependent anaerobic electron transport chains in MR-1 are clearly distinct from those in aerobic cells as aerobic MR-1 does not require menaquinone (38) or CymA.
Branched electron transport chains are not uncommon, particularly in species able to utilize numerous electron acceptors. The branched respiratory chains of P. denitrificans are perhaps one of the most studied, and their composition varies with growth conditions (58); aerobic cells contain many mitochondria-like components (58), while many additional cytochromes are produced only under anaerobic conditions (7) . Similarly in MR-1 both the content and subcellular distribution of cyto- chromes are much different in aerobic versus anaerobic cells, with anaerobic cells possessing a more complex array of cytochromes (36) . It is clear that in P. denitrificans specific soluble cytochromes c are involved in specific electron transport routes (57) . This may also be the case for at least some cytochromes in Shewanella, especially given the complexity of its cytochrome content. In support of this, the fumarate reductase from S. putrefaciens NCMB 400 is a periplasmic flavocytochrome c (31, 48) . In contrast, CymA in MR-1 is clearly a common component of a branched electron transport chain.
Since our current knowledge about the other electron transport components of MR-1 is limited, it is difficult to discern the precise components with which CymA interacts to facilitate electron transfer. It is interesting that a menaquinone-deficient mutant of MR-1 (CMA-1), which is restored to the wild-type phenotype by a precursor in the menaquinone synthesis pathway, shares the same electron transport deficiencies as the CymA-deficient mutant (38) . This suggests the possibility that CymA is somehow involved in the transfer of electrons from menaquinone to other as-yet-unidentified components.
Further insight into the specific role of CymA may be provided by examining the role of other bacterial multiheme ctype cytochromes with which CymA shares some sequence homology (Fig. 9) . The function, when known, of these matching proteins is without exception in anaerobic electron transport, lending further support for this role for CymA in MR-1. Evidence suggests that many of these proteins (TorC, NirT, and NapC) are likely attached to the periplasmic face of the CM, presumably by a hydrophobic N-terminal region, and that their hydrophilic C termini extend into the periplasmic space, thereby facilitating electron transfer to periplasmic acceptors (6, 22, 30) . For example, the NapC of Thiosphaera pantotropha may transfer electrons between the membrane ubiquinol pool and the periplasmic nitrate reductase (6), but it remains unclear whether NapC is itself the quinol oxidase (6) . Since the CymA-deficient mutant of MR-1 bears the same electron transport deficiencies as a menaquinone-deficient mutant, it is possible that the role of CymA in MR-1 is to transfer electrons from menaquinone to periplasmic or OM components. Consistent with this is the fact that the fumarate reductase of S. putrefaciens MR-1 and NCMB400 is periplasmic (31, 35, 48) and the Fe(III) reductase of MR-1 is in the OM (37) . The location of the nitrate reductase in MR-1 is not yet known, but a requirement for CymA suggests the possibility that it may be periplasmic. In contrast, the TorC protein of E. coli is not required for fumarate and nitrate reduction, but these are CM-associated activities in E. coli (13, 56 ) so one would not expect the need for this type of electron carrier. However, this menaquinone-to-periplasm electron transfer role for CymA in MR-1 remains speculative at this point. A more thorough knowledge of other electron transport components in MR-1 will be required before the precise role of CymA can be discerned. It is clear from the phenotype of the mutant, however, that CymA is one of the components necessary for electron transfer to terminal reductases which are localized outside the cell proper, i.e., in the periplasm or the OM. The requirement for CymA for Fe(III) reduction and a marked role for CymA for Mn(IV) reduction in MR-1 are very interesting. Since oxides of Mn(IV) and Fe(III) are generally very insoluble in water, MR-1 must somehow establish a link between its electron transport system and extracellular insoluble metal oxides. The majority of Fe(III) reductase activity in MR-1 is localized in the OM, with none detected in the periplasm (37) . MR-1 also localizes a majority of its membrane-bound cytochromes to its OM when grown under anaerobic conditions (36) . It is possible that these OM cytochromes are involved in the respiratory reduction of Fe(III) and Mn(IV) (36, 37) . CymA could have a role in mediating electron transfer from the CM to the OM. If so, possible mechanisms would include direct transfer to some component(s) in the OM or indirect transfer through periplasmic electron carriers, e.g., cytochromes. Since CymA is also necessary for fumarate reduction, which is a periplasmic activity, its role may be in electron transfer to a periplasmic acceptor(s). This is consistent with the expectation that c-type cytochromes serve periplasmic electron transfer roles (63) . For c-type cytochromes in Paracoccus, heme attachment occurs only after their translocation to the external face of the CM (46, 47) . If this is also the case in MR-1, it further argues for a periplasmic exposure of CymA. At this point, however, the identity of the component(s) that accepts electrons from CymA remains unknown.
The role of CymA in electron transport is not limited to the use of a single electron acceptor as is the case for the cytochromes with which it shares partial sequence homology (Fig.  9 ). Its closest match is to the CM-bound TorC protein of E. coli (30) , with 32.6% sequence identity; the overall homology is 48.6% if analogous substitutions are considered, and homology is greatest in the heme c binding regions (Fig. 9) . The TorC protein in E. coli presumably serves to transfer electrons to the periplasmic TMAO reductase (TorA) (30) . While S. putrefaciens NCMB 400 possesses two periplasmic TMAO reductases (12) , it is clear that CymA is not required for TMAO-linked respiration in MR-1 ( Table 2 ). If MR-1 similarly possesses two TMAO reductases, it is possible that CymA is involved in electron transfer to one of them but that the other is sufficient for TMAO respiration. But since TorC in E. coli is exclusively associated with TMAO reduction, its role is clearly different from that of CymA in MR-1.
NirT of Pseudomonas stutzeri, which has 31.0% sequence identity and 46.5% sequence homology with CymA ( Fig. 9) , is required for nitrite reduction but is not itself the nitrite reductase (22) . NirT presumably transfers electrons between the CM and an electron acceptor in the periplasm of P. stutzeri (either cytochrome c 551 or the nitrite reductase itself) (22) . While the potential role of CymA in nitrite reduction in MR-1 remains unknown at this time, it is clearly different from that of NirT in that it is required for the reduction of several electron acceptors. CymA has 29.9 to 31.6% sequence identity and 45.5 to 48.7% sequence homology with the NapC proteins of E. coli, Haemophilus influenzae, Thiosphaera pantotropha, and Rhodobacter sphaeroides (Fig. 9) , which are components of their nitrate reductase operons. Specifically, the role of NapC in both R. sphaeroides and T. pantotropha is to direct electron flow to their periplasmic nitrate reductase (6) . While CymA is required for nitrate reduction in MR-1 (Table 2) , its role is not restricted to nitrate reduction so it is not identical to the role for these NapC proteins.
It would therefore appear that the role of CymA in MR-1 is analogous, but not identical, to that of a related group of multiheme c-type cytochromes that are required for certain types of electron transport. It seems that they likely share a role for mediating electron flow between quinones in the CM and electron-accepting proteins on the external side of the cell proper (i.e., in the periplasm or possibly even the OM in the case of MR-1).
In summary, while additional studies will be required to better understand the membrane topology and electron transport role of CymA, the data show that cymA encodes a 21-kDa tetraheme cytochrome c that is required for growth on fumarate and for the reduction of nitrate and Fe(III). Its potential role as a mediator of electron transport between the CM and the periplasm/OM is particularly intriguing and will likely contribute to our understanding of the remarkable anaerobic respiratory diversity of this bacterium. FIG. 9 . Amino acid sequence similarities between CymA protein of MR-1 and the best matches as identified by BLAST. Sequence alignments were done by using the pam250 matrix of MacVector software. Identical residues are indicated by uppercase letters, analogous residues are indicated by lowercase letters, and unmatched residues are indicated by dots. Some alignments were facilitated by introducing a one-residue gap (-) or by the removal of one or more residues ( P). The numbers on the right indicate the relative numbering of residues within each protein; the total number of residues in each protein is shown in parentheses at the end of each sequence. Comparative sequences and their database accession numbers are as follows: TorC E.coli (Swiss-Protein P33226, E. coli TorC, CM bound, required for TMAO reduction); NapC E.coli (Swiss-Protein P33932, E. coli NapC, part of nitrate reductase operon); NirT P.stut (Swiss-Protein P24038, P. stutzeri NirT, membrane anchored, required for nitrite reduction); NapC H.infl (Swiss-Protein P44655, H. influenzae NapC, strong analogy to NirT, putative role in nitrate reduction); NapC T.pant (PIR-Protein S50165, T. pantotropha, tetraheme cytochrome c, membrane anchored, part of periplasmic nitrate reductase operon); and NapC R.spha (GenBank Z46806, Rhodobacter sphaeroides NapC, CM bound, part of periplasmic nitrate reductase operon). All are bacterial tetraheme c-type cytochromes, except for E. coli TorC, which has five heme c-binding sites.
